Stocks › NEOG

NEOGEN CORP

NEOG·Nasdaq·United States United States·USD
$10.55
-0.30 (-2.76%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
NEOG
NEOGEN CORP · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
NEOGS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of NEOG by members of U.S. Congress · 5 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Greg GianforteGreg GianforteHouse · R · MT NEOGNEOGEN CORP · Stock Sale
$1,001 - $15,000
Nov 9, 2020 Oct 13, 2020 Filing ↗
Donna ShalalaDonna ShalalaHouse · D · FL NEOGNEOGEN CORP · Stock Sale
$1,001 - $15,000
Apr 27, 2020 Jun 24, 2019 Filing ↗
Greg GianforteGreg GianforteHouse · R · MT NEOGNEOGEN CORP · Stock Purchase
$100,001 - $250,000
Jul 1, 2019 Jun 12, 2019 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH NEOGNEOGEN CORP · Stock Sale
$1,001 - $15,000
Jan 27, 2016 Jan 7, 2016 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH NEOGNEOGEN CORP · Stock Purchase
$1,001 - $15,000
Oct 5, 2015 Sep 24, 2015 Filing ↗

Whale Activity

Position changes in NEOG reported for 2026-09-30 by 365 institutional filers
Increased: 115New: 52Held: 58Decreased: 96Closed: 28No prior filing: 16
  • Increased115
  • New52
  • Held58
  • Decreased96
  • Closed28
  • No prior filing16
FilerSharesValueChange
BlackRock, Inc.33.0M$422.1Mdecreased
Neuberger Berman Group LLC14.9M$190.9Mdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC13.0M$166.0Mdecreased
DIMENSIONAL FUND ADVISORS LP10.3M$131.6Mincreased
VANGUARD CAPITAL MANAGEMENT LLC9.7M$123.8Mincreased
STATE STREET CORP8.9M$114.1Mdecreased
ING GROEP NV8.7M$112.0Mdecreased
T. Rowe Price Investment Management, Inc.8.5M$108.8Mdecreased
Gates Capital Management, Inc.7.4M$94.9Mdecreased
NOMURA HOLDINGS INC6.6M$84.2Mincreased
GEODE CAPITAL MANAGEMENT, LLC5.6M$71.9Mdecreased
BAMCO INC /NY/5.0M$64.2Mheld

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by NEOG insiders, by quarter · Form 4
-200.0K-100.0K0100.0K200.0K2025 Q1: 37.8K2025 Q12025 Q2: 152.5K2025 Q22025 Q3: 02025 Q32025 Q4: 1772025 Q42026 Q1: 2092026 Q12026 Q2: 02026 Q22026 Q3: 3702026 Q32026 Q4: -8,5462026 Q4

Recent Insider Transactions

1,670 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Yarwood JeremyChief Scientific Officer Sale −9,051 $12.67 $115K Nov 4, 2026 Form 4 ↗
Nassif MikhealCEO · Director Purchase +505 $11.95 $6K Oct 9, 2026 Form 4 ↗
Moylan John PatrickChief Accounting Officer Tax withholding −2,365 $11.87 $28K Aug 19, 2026 Form 4 ↗
Nassif MikhealCEO · Director Tax withholding −20.4K $11.87 $242K Aug 19, 2026 Form 4 ↗
Moylan John PatrickChief Accounting Officer Grant / award +8,584 $11.65 $100K Aug 14, 2026 Form 4 ↗
Ranalli Tamara A.Senior Vice President Grant / award +25.8K $11.65 $300K Aug 14, 2026 Form 4 ↗
Stacey Jennifer EvansChief Legal Officer Grant / award +38.6K $11.65 $450K Aug 14, 2026 Form 4 ↗
Riggsbee Richard BryanCFO Grant / award +51.5K $11.65 $600K Aug 14, 2026 Form 4 ↗
Nassif MikhealCEO · Director Grant / award +141.6K $11.65 $1.7M Aug 14, 2026 Form 4 ↗
Nassif MikhealCEO · Director Purchase +370 $11.81 $4K Aug 4, 2026 Form 4 ↗
Moylan John PatrickChief Accounting Officer Tax withholding −2,553 $8.75 $22K Jun 3, 2026 Form 4 ↗
Rocklin Amy MFormer Chief Legal Officer Tax withholding −10.2K $9.29 $95K May 18, 2026 Form 4 ↗
Rocklin Amy MFormer Chief Legal Officer Option exercise +35.2K $9.29 $327K May 18, 2026 Form 4 ↗
Moylan John PatrickChief Accounting Officer Tax withholding −1,568 $9.53 $15K May 4, 2026 Form 4 ↗
Moylan John PatrickChief Accounting Officer Option exercise +4,558 $9.53 $43K May 4, 2026 Form 4 ↗
Stacey Jennifer EvansChief Legal Officer Grant / award +39.3K $9.53 $375K May 1, 2026 Form 4 ↗
Nassif MikhealCEO · Director Purchase +23 $10.94 $252 Feb 17, 2026 Form 4 ↗
Nassif MikhealCEO · Director Purchase +24 $10.00 $240 Feb 2, 2026 Form 4 ↗
Nassif MikhealCEO · Director Purchase +25 $9.86 $247 Jan 26, 2026 Form 4 ↗
Nassif MikhealCEO · Director Purchase +137 $9.33 $1K Jan 16, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding NEOG · SEC Form N-PORT
FundSharesValue% of fundAs of
iShares Core S&P Small-Cap ETF
iShares Trust
13.1M$117.9M0.11%Jun 30, 2026
Neuberger Genesis Fund
NEUBERGER BERMAN EQUITY FUNDS
7.5M$86.6M1.19%Aug 31, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
6.9M$62.3M0.00%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
5.8M$51.9M0.06%Jun 30, 2026
BARON SMALL CAP FUND
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)
5.0M$45.0M1.58%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
5.0M$44.8M0.02%Jun 30, 2026
U.S. SMALL CAP VALUE PORTFOLIO
DFA INVESTMENT DIMENSIONS GROUP INC
2.9M$35.5M0.18%Jul 31, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
2.4M$29.2M0.09%Jul 31, 2026
VANGUARD SMALL-CAP VALUE INDEX FUND
VANGUARD INDEX FUNDS
3.2M$28.4M0.04%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
2.5M$22.5M0.02%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list NEOG's shares (CUSIP 640491106), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Neuberger Berman Investment Advisers LLCSCHEDULE 13G · passive (13G) · 16.1M shares7.4%
    Jul 7, 2026 · ↗
  • Neuberger Berman Group LLCSCHEDULE 13G · passive (13G) · 16.6M shares7.6%
    Jul 7, 2026 · ↗
  • Gerald W. HakalaSCHEDULE 13G/A · passive (13G) · 2.2M shares1.0%
    May 14, 2026 · ↗
  • Jeffrey A. HakalaSCHEDULE 13G/A · passive (13G) · 2.2M shares1.0%
    May 14, 2026 · ↗
  • Clarkston Companies, Inc.SCHEDULE 13G/A · passive (13G) · 2.2M shares1.0%
    May 14, 2026 · ↗
  • Clarkston Capital Partners, LLCSCHEDULE 13G/A · passive (13G) · 2.2M shares1.0%
    May 14, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming neogen as client
$0$50K$100K$150K$200K2023 Q1: $20K2023 Q2: $20K2023 Q3: $20K2023 Q4: $30K20232024 Q1: $30K2024 Q2: $30K2024 Q3: $30K2024 Q4: $30K20242025 Q1: $30K2025 Q2: $30K2025 Q3: $30K2025 Q4: $30K20252026 Q1: $30K2026 Q2: $30K2026 Q3: $30K2026
  • THE RUSSELL GROUP, INC.NEOGEN CORPORATION · 2026 Q3 · FOO$30K
    Filing ↗
  • THE RUSSELL GROUP, INC.NEOGEN CORPORATION · 2026 Q2 · FOO$30K
    Filing ↗
  • THE RUSSELL GROUP, INC.NEOGEN CORPORATION · 2026 Q1 · FOO$30K
    Filing ↗
  • THE RUSSELL GROUP, INC.NEOGEN CORPORATION · 2025 Q4 · FOO$30K
    Filing ↗
  • THE RUSSELL GROUP, INC.NEOGEN CORPORATION · 2025 Q3 · FOO$30K
    Filing ↗

Government Contracts

Federal awards to neogen · USAspending
$722KAwarded · 12 contracts on record
  • Department of AgricultureEASTERN LAB, MIDWEST LAB, WESTERN LAB Q1 FY27 TASK ORDERS FOR UVM BROTH FOR CONTRACT 123A9422D0009 WITH NEOGEN; DELIVERY DATES JANUARY-APRIL$23K
    Nov 19, 2026 · ↗
  • Department of AgricultureIGF::OT::IGF$8K
    Jun 20, 2013 · ↗
  • Department of AgricultureDELIVERY ORDER FOR ZINC PHOSPHIDE 82%$15K
    Jun 29, 2026 · ↗
  • Department of AgricultureDO FOR LISTERIA AND SALMONELLA DETECTION KITS FOR EL, MWL, WL, AND NARMS UNDER CONTRACT 123A9424D0005; DELIVERY DATES MAY - AUGUST$145K
    Apr 13, 2026 · ↗
  • Department of AgricultureEASTERN LAB, NARMS, MIDWEST LAB, WESTERN LAB DELIVERY ORDERS FOR LM, L. SPECIES, SALMONELLA$156K
    Aug 16, 2026 · ↗
  • Department of Veterans AffairsCLEAN-TRACE CALIBRATION AND MAINTENANCE SERVICES$5K
    Jan 2, 2024 · ↗
  • Department of AgricultureQ4 FY26 TASK ORDER FOR CAMPY ENRICHMENT BROTH ON CONTRACT 123A9423D0008 WITH NEOGEN FOR ALL 3 LABS$956
    Jun 18, 2026 · ↗
  • Department of AgricultureDELIVERY ORDER FOR NEOGEN UVM, MTSB, AND BPW BROTHS UNDER CONTRACT 123A9422D0009; DELIVERY DATE 3/19/2025$0
    Feb 7, 2025 · ↗

U.S. Patents

Recent USPTO applications naming NEOGEN CORP

No USPTO patent applications found for NEOGEN CORP.

Annual Financials

From NEOG's 10-K filings · XBRL
Fiscal yearFY2026FY2025FY2024FY2023FY2022
Revenue$870.4M$894.7M$924.2M$822.4M$527.2M
Operating income-$21.6M-$1.06B$58.6M$37.5M$58.6M
Net income-$7.9M-$1.09B-$9.4M-$22.9M$48.3M
Diluted EPS-$0.04-$5.03-$0.04-$0.12$0.45
Operating cash flow$83.2M$58.2M$35.3M$41.0M$68.0M
Cash and equivalents$185.5M$129.0M$170.6M$163.2M$44.5M
Total assets$3.35B$3.44B$4.55B$4.55B$992.9M
Total liabilities$1.25B$1.37B$1.40B$1.42B$105.6M
Shareholders' equity$2.09B$2.07B$3.14B$3.13B$887.4M

As NEOGEN CORP tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Jul 30, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 2-for-1Stock splitJun 7, 2021
  • 4-for-3Stock splitJan 2, 2018
  • 3-for-2Stock splitOct 31, 2013
  • 3-for-2Stock splitDec 16, 2009
  • 3-for-2Stock splitSep 5, 2007
  • 5-for-4Stock splitJan 2, 2004

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 8.01Other eventsNov 4, 2026
    EDGAR ↗
  • 8-K/A · Items 5.02, 9.01Officer / director changeOct 26, 2026
    EDGAR ↗
  • 8-K · Items 5.07, 9.01Shareholder voteOct 7, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsOct 6, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeAug 7, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsJul 30, 2026
    EDGAR ↗

About NEOGEN CORP

From SEC EDGAR company records

Neogen Corporation and its subsidiaries develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Our Food Safety segment consists primarily of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. We also have products to determine food quality and nutritional components. The majority of the…

Industry (SIC 2835)In Vitro & In Vivo Diagnostic Substances
SectorHealthcare
HeadquartersLANSING, MI
IncorporatedMI